One Health Enteric sample from Klebsiella pneumoni... - BioSample

One Health Enteric sample from Klebsiella pneumoniae

Identifiers: BioSample: SAMN37300943; Sample name: OHT45-2A; SRA: SRS19043386

Organism: Klebsiella pneumoniae
cellular organisms; Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Enterobacteriaceae; Klebsiella; Klebsiella pneumoniae complex

Package: One Health Enteric; version 1.0

Attributes

strain	OHT45-2A
collected by	The Ohio State University
collection date	2021-05-03
geographic location	USA:OH
isolation source	Pig ear pet treat
source type	other
purpose of sampling	Surveillance program
project name	Antimicrobial resistance
sequenced by	CVM
host	missing

BioProjects: PRJNA1118811 OHT45-2A
Retrieve all samples from this project

PRJNA800017 Isolates from retail Sea Food
Retrieve all samples from this project

Submission: FDA-CVM, FDA CVM; 2023-09-06

Antibiogram
Antibiotic	Resistance phenotype	Measurement sign	Measurement	Measurement units	Laboratory typing method	Laboratory typing platform	Vendor	Laboratory typing method version or reagent	Testing standard
amikacin	susceptible	<=	4	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
amoxicillin-clavulanic acid	susceptible	==	4/2	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
ampicillin	resistant	==	32	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
azithromycin	not defined	==	8	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
aztreonam	susceptible	<=	2	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
cefepime	susceptible	<=	2	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
cefotaxime	susceptible	<=	1	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
cefoxitin	susceptible	==	2	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
ceftazidime	susceptible	<=	1	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
ceftriaxone	susceptible	<=	0.25	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
chloramphenicol	susceptible	==	8	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
ciprofloxacin	susceptible	<=	0.25	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
colistin	resistant	>	4	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
doripenem	susceptible	<=	0.12	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
doxycycline	resistant	>	16	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
ertapenem	susceptible	<=	0.25	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
gentamicin	susceptible	<=	1	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
imipenem	susceptible	<=	1	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
levofloxacin	susceptible	<=	1	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
meropenem	susceptible	<=	1	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
minocycline	susceptible	==	8	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
nalidixic acid	susceptible	==	2	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
piperacillin-tazobactam	susceptible	<=	8/4	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
polymyxin B	resistant	>	4	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
streptomycin	not defined	<=	2	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
sulfisoxazole	not defined	>	256	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
tetracycline	resistant	>	32	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
ticarcillin-clavulanic acid	susceptible	<=	16/2	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
tigecycline	susceptible	==	0.5	mg/L	MIC	Vitek	Trek	GM-NEG	NARMS
tobramycin	susceptible	<=	1	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI
trimethoprim-sulfamethoxazole	resistant	>	4/76	mg/L	MIC	Vitek	Trek	GM-NEG	CLSI

Accession:: SAMN37300943
ID:: 37300943

BioProject SRA Nucleotide

BioSample

National Center for Biotechnology Information

Result Filters

Send to:

One Health Enteric sample from Klebsiella pneumoniae

Supplemental Content

Related information

Recent activity